从药物警戒观试析《伤寒论》的“误下及下法禁忌”  

Erroneous purgation and contraindication of purgative therapy in Shanghanlun analysed based on pharmacovigilance

作　　者：陈炯华[1,2] 王永炎[1] 谢雁鸣[1] 申春悌[3] 

机构地区：[1]中国中医科学院中医临床基础医学研究所,北京100700 [2]江苏省中医药研究院 [3]南京中医药大学附属常州医院

出　　处：《北京中医药大学学报》2010年第3期149-152,共4页Journal of Beijing University of Traditional Chinese Medicine

基　　金：中国博士后基金资助项目(No.20080430069);"重大新药创制"科技重大专项资助项目(No.2009XZ09502-030)

摘　　要：为从中医药学经典理论中挖掘、研究中药不良反应,并结合现代"药物警戒"观点,就仲景《伤寒论》"误下、下法禁忌"条文,且针对其"变证"的临证特点、分类、机理及救治方法作了分析和探讨,初步归纳了"下法禁忌"12种。本研究表明深入研究经典有助于提高中医药疗效、防止中药不良反应,警示医者不能以药试病,错投误治。The paper tried to analyse and discuss the characteristics,classification,pathogenesis and therapies of deteriorated syndromes induced by erroneous purgation according to the articles of erroneous purgation and contraindication of purgative therapy in Shanghanlun.The analysis was carried out from the aspect of modern concept of pharmacovigilance for mining and studying the adverse reactions of Chinese herbal remedies in TCM classical theory.There were 12 contraindications of purgative therapy summed up.The study on classics is conducive for improving the curative effect of Chinese medicine and preventing the adverse reactions of Chinese herbal remedies,which will warn physicians not to cure disease experimentally with medicines,and not to use wrong drugs and improper therapies.

关 键 词：误下 变证 下法禁忌 不良反应 

分 类 号：R222.2[医药卫生—中医基础理论]